KLF5 and intestinal neoplasm: In contrast, both ApcMin/KRASV12 and ApcMin/KRASV12/Klf5+/- mice contained a higher percentage of intestinal tumors in the proximal small intestine, duodenum (44% and 64%, respectively) when compared to the ApcMin mice (7%) (Fig. 2B).